Overview

Ayahuasca and Esketamine for Major Depression

Status:
COMPLETED
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Double-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.
Phase:
PHASE2
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Esketamine